Search Results

Use of olopatadine ophthalmic solution and reactivity of histamine skin testing

Authors: Jones, Jeremy D.; Temino, Viviana M.; Dworski, Ryszard; Anderson, Cindy K.; Fahrenholz, John M.; An, Angel Qi

Source: Allergy and Asthma Proceedings, Volume 29, Number 6, November-December 2008 , pp. 636-639(4)

Publisher: OceanSide Publications, Inc

A comparison of olopatadine 0.2% ophthalmic solution versus fluticasone furoate nasal spray for the treatment of allergic conjunctivitis

Authors: Rosenwasser, Lanny J.; Mahr, Todd; Abelson, Mark B.; Gomes, Paul J.; Kennedy, Kathryn

Source: Allergy and Asthma Proceedings, Volume 29, Number 6, November-December 2008 , pp. 644-653(10)

Publisher: OceanSide Publications, Inc

Olopatadine 0.2% ophthalmic solution: the first ophthalmic antiallergy agent with once-daily dosing

Authors: Abelson, Mark B; Gomes, Paul J

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 4, Number 4, April 2008 , pp. 453-461(9)

Publisher: Informa Healthcare

Evaluation of the effects of olopatadine ophthalmic solution, 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye

Authors: Mah, F.S.; O'Brien, T.; Kim, T.; Torkildsen, G.

Source: Current Medical Research and Opinion, Volume 24, Number 2, February 2008 , pp. 441-447(7)

Publisher: Informa Healthcare

Efficacy of Once-Daily Olopatadine 0.2% Ophthalmic Solution Compared to Twice-Daily Olopatadine 0.1% Ophthalmic Solution for the Treatment of Ocular Itching Induced by Conjunctival Allergen Challenge

Authors: Abelson, Mark; Spangler, Dennis; Epstein, Arthur; Mah, Francis; Crampton, H. Jerome

Source: Current Eye Research, Volume 32, Number 12, December 2007 , pp. 1017-1022(6)

Publisher: Informa Healthcare

Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis

Authors: Abelson, Mark B.; Gomes, Paul J.; Pasquine, Terri; Edwards, Michael R.; Gross, Robert D.; Robertson, Stella M.

Source: Allergy and Asthma Proceedings, Volume 28, Number 4, July-August 2007 , pp. 427-433(7)

Publisher: OceanSide Publications, Inc

Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge

Authors: Mah, Francis S.; Rosenwasser, Lanny J.; Townsend, William D.; Greiner, Jack V.; Bensch, George

Source: Current Medical Research and Opinion, Volume 23, Number 6, June 2007 , pp. 1445-1452(8)

Publisher: Informa Healthcare

Once-daily olopatadine ophthalmic solution 0.2% in the treatment of allergic conjunctivitis and rhinoconjunctivitis

Author: Berger, William E

Source: Expert Review of Pharmacoeconomics and Outcomes Research, Volume 7, Number 3, June 2007 , pp. 221-226(6)

Publisher: Expert Reviews

Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy

Authors: Berger, William; Abelson, Mark B.; Gomes, Paulo J.; Beck, Morris; Kimura, Stephen; Westbrook, Thomas; Storms, William; Galant, Stanley

Source: Annals of Allergy, Asthma and Immunology, Volume 95, Number 4, October 2005 , pp. 361-371(11)

Publisher: American College of Allergy, Asthma, & Immunology

Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research

Authors: Rosenwasser, Lanny J.; O'Brien, Terrence; Weyne, Jonathan

Source: Current Medical Research and Opinion, Volume 21, Number 9, September 2005 , pp. 1377-1388(12)

Publisher: Informa Healthcare

Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis

Authors: Abelson, Mark B.; Gomes, Paul J.; Vogelson, Cullen T.; Pasquine, Terri A.; Turner, F. Darell; Wells, David T.; Robertson, Stella M.

Source: Current Medical Research and Opinion, Volume 21, Number 5, May 2005 , pp. 683-692(10)

Publisher: Informa Healthcare

Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model

Authors: Abelson, Mark B.; Greiner, Jack V.

Source: Current Medical Research and Opinion, Volume 20, Number 12, December 2004 , pp. 1953-1958(6)

Publisher: Informa Healthcare

A review of olopatadine for the treatment of ocular allergy

Author: Mark B Abelson

Source: Expert Opinion on Pharmacotherapy, Volume 5, Number 9, 1 September 2004 , pp. 1979-1994(16)

Publisher: Informa Healthcare

Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model

Authors: Lanier, Bobby Q.; Finegold, Ira; D'Arienzo, Peter; Granet, David; Epstein, Arthur B.; Ledgerwood, Greg L.

Source: Current Medical Research and Opinion, Volume 20, Number 8, 1 August 2004 , pp. 1227-1233(7)

Publisher: Informa Healthcare

Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models

Authors: Spangler D.L.; Abelson M.B.; Ober A.; Gotnes P.J.

Source: Clinical Therapeutics, Volume 25, Number 8, August 2003 , pp. 2245-2267(23)

Publisher: Elsevier

One-visit, randomized, placebo-controlled, conjunctival allergen challenge study of scanning and imaging technology for objective quantification of eyelid swelling in the allergic reaction with contralateral use of olopatadine and artificial tears

Authors: belson M.B.; Pratt S.; Mussoline J.E.; Townsend D.

Source: Clinical Therapeutics, Volume 25, Number 7, July 2003 , pp. 2070-2084(15)

Publisher: Elsevier

Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis

Authors: Yaylali, Volkan; Demirlenk, Ibrahim; Tatlipinar, Sinan; Özbay, Davut; Esme, Arif; Yildirim, Cem; Özden, Serap

Source: Acta Ophthalmologica Scandinavica, Volume 81, Number 4, August 2003 , pp. 378-382(5)

Publisher: Blackwell Publishing

A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjuctivitis and rhinoconjunctivitis

Authors: Abelson M.B.; Turner D.

Source: Clinical Therapeutics, Volume 25, Number 3, March 2003 , pp. 931-947(17)

Publisher: Elsevier

A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis

Authors: Katelaris C.H.; Ciprandi G.; Missotten L.; Turner F.D.; Bertin D.; Berdeaux G.; International Olopatadine Study Group

Source: Clinical Therapeutics, Volume 24, Number 10, October 2002 , pp. 1561-1575(15)

Publisher: Elsevier

Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms

Authors: Lanier, Bobby Q.; Gross, Robert D.; Marks, Bethany B.; Cockrum, Paul C.; Juniper, Elizabeth F.; MCSP

Source: Annals of Allergy, Asthma and Immunology, Volume 86, Number 6, June 2001 , pp. 641-648(8)

Publisher: American College of Allergy, Asthma, & Immunology